Published in J Biol Chem on October 10, 1983
Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol (2011) 4.67
Biosynthesis of 15-deoxy-delta12,14-PGJ2 and the ligation of PPARgamma. J Clin Invest (2003) 2.27
Δ12-prostaglandin J3, an omega-3 fatty acid-derived metabolite, selectively ablates leukemia stem cells in mice. Blood (2011) 2.22
Importance of group X-secreted phospholipase A2 in allergen-induced airway inflammation and remodeling in a mouse asthma model. J Exp Med (2007) 1.96
Isoprostane generation and function. Chem Rev (2011) 1.41
Activated human T lymphocytes express cyclooxygenase-2 and produce proadipogenic prostaglandins that drive human orbital fibroblast differentiation to adipocytes. Am J Pathol (2006) 1.32
15-Deoxy-Delta(12,14)-prostaglandin J(2): the endogenous electrophile that induces neuronal apoptosis. Proc Natl Acad Sci U S A (2002) 1.28
An improved LC-MS/MS method for the quantification of prostaglandins E(2) and D(2) production in biological fluids. Anal Biochem (2007) 1.25
Inhibition of IgE-dependent histamine release from human dispersed lung mast cells by anti-allergic drugs and salbutamol. Br J Pharmacol (1987) 1.24
Formation of highly reactive cyclopentenone isoprostane compounds (A3/J3-isoprostanes) in vivo from eicosapentaenoic acid. J Biol Chem (2008) 1.15
Redox signaling, alkylation (carbonylation) of conserved cysteines inactivates class I histone deacetylases 1, 2, and 3 and antagonizes their transcriptional repressor function. J Biol Chem (2010) 1.13
Targeting PPAR receptors in the airway for the treatment of inflammatory lung disease. Br J Pharmacol (2009) 1.13
9-Deoxy-delta 9, delta 12-13,14-dihydroprostaglandin D2, a metabolite of prostaglandin D2 formed in human plasma. Proc Natl Acad Sci U S A (1984) 1.10
15-Deoxy-delta12,14-PGJ2: endogenous PPARgamma ligand or minor eicosanoid degradation product? J Clin Invest (2003) 1.08
PPARs and lipid ligands in inflammation and metabolism. Chem Rev (2011) 1.06
Alkylation of the tumor suppressor PTEN activates Akt and β-catenin signaling: a mechanism linking inflammation and oxidative stress with cancer. PLoS One (2010) 1.00
Cyclooxygenase-2 deficiency attenuates adipose tissue differentiation and inflammation in mice. J Biol Chem (2010) 1.00
Inactivation of wild-type p53 tumor suppressor by electrophilic prostaglandins. Proc Natl Acad Sci U S A (2000) 0.99
Cyclopentenone prostaglandin-induced unfolding and aggregation of the Parkinson disease-associated UCH-L1. Proc Natl Acad Sci U S A (2010) 0.99
Peroxisome proliferator-activated receptor gamma ligands enhance human B cell antibody production and differentiation. J Immunol (2009) 0.95
Preferential binding of growth inhibitory prostaglandins by the target protein of a carcinogen. Proc Natl Acad Sci U S A (1990) 0.95
The eicosapentaenoic acid metabolite 15-deoxy-δ(12,14)-prostaglandin J3 increases adiponectin secretion by adipocytes partly via a PPARγ-dependent mechanism. PLoS One (2013) 0.92
Cyclopentenone eicosanoids as mediators of neurodegeneration: a pathogenic mechanism of oxidative stress-mediated and cyclooxygenase-mediated neurotoxicity. Brain Pathol (2005) 0.92
11-Oxoeicosatetraenoic acid is a cyclooxygenase-2/15-hydroxyprostaglandin dehydrogenase-derived antiproliferative eicosanoid. Chem Res Toxicol (2011) 0.91
Regulation of Lymphocyte Function by PPARgamma: Relevance to Thyroid Eye Disease-Related Inflammation. PPAR Res (2008) 0.90
15-Deoxy- γ 12,14-prostaglandin J2 Reduces Liver Impairment in a Model of ConA-Induced Acute Hepatic Inflammation by Activation of PPAR γ and Reduction in NF- κ B Activity. PPAR Res (2014) 0.89
The anti-inflammatory prostaglandin 15d-PGJ2 decreases oxidative/nitrosative mediators in brain after acute stress in rats. Psychopharmacology (Berl) (2005) 0.87
Targeting 15d-prostaglandin J2 to hepatic stellate cells: two options evaluated. Pharm Res (2007) 0.86
15-Deoxy-Delta12,14-prostaglandin J2 inhibits HIV-1 transactivating protein, Tat, through covalent modification. FASEB J (2009) 0.86
CXCR4 in Cancer and Its Regulation by PPARgamma. PPAR Res (2008) 0.85
The cyclopentenone prostaglandin 15d-PGJ2 inhibits the NLRP1 and NLRP3 inflammasomes. J Immunol (2015) 0.83
Role of peroxisome proliferator-activated receptor gamma and its ligands in the treatment of hematological malignancies. PPAR Res (2008) 0.83
Inhibitory effects of prostaglandin D2 against the proliferation of human colon cancer cell lines and hepatic metastasis from colorectal cancer. Surg Today (1998) 0.83
Cerebral arachidonate cascade in dementia: Alzheimer's disease and vascular dementia. Curr Neuropharmacol (2006) 0.83
Evaluation of the stability, bioavailability, and hypersensitivity of the omega-3 derived anti-leukemic prostaglandin: Δ(12)-prostaglandin J3. PLoS One (2013) 0.82
Nonenzymatic free radical-catalyzed generation of 15-deoxy-Δ(12,14)-prostaglandin J₂-like compounds (deoxy-J₂-isoprostanes) in vivo. J Lipid Res (2010) 0.82
Isomeric prostaglandin F2 compounds arising from prostaglandin D2: a family of icosanoids produced in vivo in humans. Proc Natl Acad Sci U S A (1988) 0.79
Prostaglandin A2 enhances cellular insulin sensitivity via a mechanism that involves the orphan nuclear receptor NR4A3. Horm Metab Res (2012) 0.78
Early increase in alveolar macrophage prostaglandin 15d-PGJ2 precedes neutrophil recruitment into lungs of cytokine-insufflated rats. Inflammation (2013) 0.78
Prostaglandin D2 synthase: Apoptotic factor in alzheimer plasma, inducer of reactive oxygen species, inflammatory cytokines and dialysis dementia. J Nephropathol (2013) 0.78
Eosinophils Contribute to Intestinal Inflammation via Chemoattractant Receptor-homologous Molecule Expressed on Th2 Cells, CRTH2, in Experimental Crohn's Disease. J Crohns Colitis (2016) 0.77
Identification of a prostaglandin D2 metabolite as a neuritogenesis enhancer targeting the TRPV1 ion channel. Sci Rep (2016) 0.77
Receptors involved in the modulation of guinea pig urinary bladder motility by prostaglandin D2. Br J Pharmacol (2015) 0.77
Observation of two modes of inhibition of human microsomal prostaglandin E synthase 1 by the cyclopentenone 15-deoxy-Δ(12,14)-prostaglandin J(2). Biochemistry (2012) 0.76
Blood plasma influences anti-aggregatory potency of prostaglandins: effect of albumin. Inflammopharmacology (1999) 0.76
Chemoattractant receptor homologous to the T helper 2 cell (CRTH2) is not expressed in human amniocytes and myocytes. PLoS One (2012) 0.75
Prostaglandins and Their Receptors in Eosinophil Function and As Therapeutic Targets. Front Med (Lausanne) (2017) 0.75
Selective inhibition of receptor-coupled phospholipase C-dependent processes in human platelets and polymorphonuclear neutrophils. J Pharmacol Exp Ther (1990) 3.55
Cyclooxygenase-2 and carcinogenesis. Biochim Biophys Acta (2000) 1.95
Anaphylactic release of thromboxane A2, prostaglandin D2, and prostacyclin from human lung parenchyma. Am Rev Respir Dis (1981) 1.86
Albumin stabilizes leukotriene A4. J Biol Chem (1982) 1.35
Convergence of hormones, inflammation, and energy-related factors: a novel pathway of cancer etiology. Cancer Prev Res (Phila) (2009) 1.32
Electrophilic prostaglandins and lipid aldehydes repress redox-sensitive transcription factors p53 and hypoxia-inducible factor by impairing the selenoprotein thioredoxin reductase. J Biol Chem (2002) 1.29
Pharmacophore model for novel inhibitors of ubiquitin isopeptidases that induce p53-independent cell death. Mol Pharmacol (2002) 1.28
The bifunctional enzyme leukotriene-A4 hydrolase is an arginine aminopeptidase of high efficiency and specificity. J Biol Chem (1994) 1.27
Inhibition of phospholipase C dependent processes by U-73, 122. Adv Prostaglandin Thromboxane Leukot Res (1989) 1.27
Leukotriene A4 hydrolase. Inhibition by bestatin and intrinsic aminopeptidase activity establish its functional resemblance to metallohydrolase enzymes. J Biol Chem (1991) 1.26
Inhibition of cyclooxygenase activity and platelet aggregation by epoxyeicosatrienoic acids. Influence of stereochemistry. J Biol Chem (1986) 1.23
Thioredoxin reductase is required for the inactivation of tumor suppressor p53 and for apoptosis induced by endogenous electrophiles. Carcinogenesis (2006) 1.20
Prostaglandin E2 and thromboxane B2 in cerebrospinal fluid of afebrile and febrile cat. Am J Physiol (1983) 1.19
Akt activation by arachidonic acid metabolism occurs via oxidation and inactivation of PTEN tumor suppressor. Oncogene (2007) 1.15
Cyclopentenone prostaglandins of the J series inhibit the ubiquitin isopeptidase activity of the proteasome pathway. J Biol Chem (2001) 1.15
Redox signaling, alkylation (carbonylation) of conserved cysteines inactivates class I histone deacetylases 1, 2, and 3 and antagonizes their transcriptional repressor function. J Biol Chem (2010) 1.13
6,9-deepoxy-6,9,-(phenylimino)-delta 6,8-prostaglandin I1, (U-60,257), a new inhibitor of leukotriene C and D synthesis: in vitro studies. Prostaglandins (1982) 1.12
Virus and interferon effects on cellular prostaglandin biosynthesis. J Immunol (1980) 1.12
Inhibition of leukotriene A4 hydrolase/aminopeptidase by captopril. J Biol Chem (1991) 1.11
Synthesis and structure of the platelet aggregation factor thromboxane A2. Nature (1985) 1.09
Erythrocyte-neutrophil interactions: formation of leukotriene B4 by transcellular biosynthesis. Proc Natl Acad Sci U S A (1986) 1.08
The stability of 13,14-dihydro-15 keto-PGE2. Prostaglandins (1980) 1.05
Acetyl glyceryl ether phosphorylcholine. Intravascular alterations following intravenous infusion into the baboon. Lab Invest (1981) 1.04
Tyrosine kinase activity modulates catalysis and translocation of cellular 5-lipoxygenase. J Biol Chem (1996) 1.02
9,11-epoxyiminoprosta-5,13-dienoic acid is a thromboxane A2 antagonist in human platelets. Nature (1978) 1.00
Inactivation of wild-type p53 tumor suppressor by electrophilic prostaglandins. Proc Natl Acad Sci U S A (2000) 0.99
A radioimmunoassay for thromboxane B2. Anal Biochem (1977) 0.98
5-Lipoxygenase contains a functional Src homology 3-binding motif that interacts with the Src homology 3 domain of Grb2 and cytoskeletal proteins. J Biol Chem (1994) 0.98
Incorporation and distribution of epoxyeicosatrienoic acids into cellular phospholipids. J Biol Chem (1992) 0.97
Prostaglandin D2 formation by malignant melanoma cells correlates inversely with cellular metastatic potential. Proc Natl Acad Sci U S A (1979) 0.95
Hapten mimic elicits antibodies recognizing prostaglandin E2. Proc Natl Acad Sci U S A (1978) 0.94
A comparison of imidazole and 9,11-azoprosta-5,13-dienoic acid. Two selective thromboxane synthetase inhibitors. Biochim Biophys Acta (1978) 0.94
Taxane-mediated gene induction is independent of microtubule stabilization: induction of transcription regulators and enzymes that modulate inflammation and apoptosis. Proc Natl Acad Sci U S A (1998) 0.94
In vivo suppression of prostaglandin biosynthesis by non-steroidal anti-inflammatory agents. Prostaglandins (1976) 0.93
Mechanism-based inactivation of leukotriene A4 hydrolase during leukotriene B4 formation by human erythrocytes. J Biol Chem (1990) 0.92
Reversible, hepatic, lysosomal phospholipidosis in rat induced by subchronic daily administration of trospectomycin sulfate. Biochem Pharmacol (1989) 0.92
Taxanes propagate apoptosis via two cell populations with distinctive cytological and molecular traits. Cell Growth Differ (1998) 0.91
Albumin-eicosanoid interactions. A model system to determine their attributes and inhibition. J Biol Chem (1984) 0.91
Albumins stabilize prostaglandin I2. Prostaglandins (1980) 0.91
Albumin-lipid interactions: prostaglandin stability as a probe for characterizing binding sites on vertebrate albumins. Biochemistry (1981) 0.90
Conditional expression of 15-lipoxygenase-1 inhibits the selenoenzyme thioredoxin reductase: modulation of selenoproteins by lipoxygenase enzymes. J Biol Chem (2004) 0.89
Epoxyeicosatrienoic acids inhibit Ca2+ entry into platelets stimulated by thapsigargin and thrombin. J Biol Chem (1992) 0.89
Irreversible inactivation of 5-lipoxygenase by leukotriene A4. Characterization of product inactivation with purified enzyme and intact leukocytes. J Biol Chem (1994) 0.88
In vivo and in vitro actions of a new selective inhibitor of leukotriene C and D synthesis. Adv Prostaglandin Thromboxane Leukot Res (1983) 0.88
Reciprocal regulation of human platelet cAMP levels by thromboxane A2 and prostacyclin. Adv Cyclic Nucleotide Res (1978) 0.87
"Suicide" inactivation of thromboxane A2 synthase. Characteristics of mechanism-based inactivation with isolated enzyme and intact platelets. J Biol Chem (1990) 0.87
A radioimmunoassay for the unstable pulmonary metabolites of prostaglandin E1 and E2: an indirect index of their in vivo disposition and pharmacokinetics. J Pharmacol Exp Ther (1982) 0.87
Modification of leukotriene A(4) hydrolase/aminopeptidase by sulfhydryl-blocking reagents: differential effects on dual enzyme activities by methyl-methane thiosulfonate. Arch Biochem Biophys (1999) 0.87
Inhibition of human platelet thromboxane synthetase by 9,11-azoprosta-5,13-dienoic acid. Proc Natl Acad Sci U S A (1977) 0.87
Mechanism-based inactivation of leukotriene A4 hydrolase/aminopeptidase by leukotriene A4. Mass spectrometric and kinetic characterization. J Biol Chem (1992) 0.86
Human neutrophil activation with interleukin-1. A role for intracellular calcium and arachidonic acid lipoxygenation. Biochem Pharmacol (1987) 0.86
Albumins activate peptide hydrolysis by the bifunctional enzyme LTA4 hydrolase/aminopeptidase. Biochemistry (1992) 0.85
"Suicide" inactivation of prostaglandin I2 synthase: characterization of mechanism-based inactivation with isolated enzyme and endothelial cells. Arch Biochem Biophys (1995) 0.85
Genomics and the discovery of new drug targets. Curr Opin Chem Biol (1999) 0.85
Platelet rich plasma transforms exogenous prostaglandin endoperoxide H2 into thromboxane A2. Prostaglandins (1977) 0.85
Leukotriene A4-hydrolase activity in guinea pig and human liver. Biochim Biophys Acta (1985) 0.85
Opioid peptides are substrates for the bifunctional enzyme LTA4 hydrolase/aminopeptidase. Prostaglandins (1992) 0.84
Effect of taxol and taxotere on gene expression in macrophages: induction of the prostaglandin H synthase-2 isoenzyme. J Immunol (1999) 0.84
A radioimmunoassay for thromboxane B2. Methods Enzymol (1982) 0.83
Indirect actions of thapsigargin on human platelets: activation of eicosanoid biosynthesis and cellular signaling pathways. J Pharmacol Exp Ther (1992) 0.83
Effect of Piriprost, a 5-lipoxygenase inhibitor, on leukocyte accumulation during thioglycollate-induced acute inflammation. Wien Klin Wochenschr (1986) 0.83
Nitric oxide modulates the activity of the hemoproteins prostaglandin I2 synthase and thromboxane A2 synthase. Arch Biochem Biophys (1997) 0.83
Cyclooxygenase-2 induction by paclitaxel, docetaxel, and taxane analogues in human monocytes and murine macrophages: structure-activity relationships and their implications. Clin Cancer Res (2002) 0.83
Regulatory role of cyclic adenosine 3',5'-monophosphate on the platelet cyclooxygenase and platelet function. Biochim Biophys Acta (1979) 0.82
Receptor antagonism of leukotriene B4 myotropic activity by the 2,6 disubstituted pyridine analog U-75302: characterization on lung parenchyma strips. J Lipid Mediat (1992) 0.82
A rapid, solid phase radioimmunoassay for prostaglandin F2alpha and its main circulating metabolite. Anal Biochem (1976) 0.82
A comparison of absorption-inhibition and absorption-elution methods in the detection of ABO(H) antigens found in vaginal samples submitted in sexual offense cases. J Forensic Sci (1978) 0.82
Cytochrome P-450-mediated metabolism of the individual enantiomers of the antidepressant agent reboxetine in human liver microsomes. Drug Metab Dispos (1999) 0.82
Arachidonic acid metabolites do not mediate modulation of neurotransmitter release by adenosine in rat hippocampus or striatum. Brain Res (1990) 0.82
5-Lipoxygenase compartmentalization in granulocytic cells is modulated by an internal bipartite nuclear localizing sequence and nuclear factor kappa B complex formation. Arch Biochem Biophys (1998) 0.82
High-performance liquid chromatographic assay for prostacyclin. J Chromatogr (1979) 0.81
Comparison between circulating interferon and drug levels following administration of 2-amino-5-bromo-6-phenyl-4(3H)-pyrimidinone (ABPP) to different animal species. J Interferon Res (1982) 0.81
Prostaglandin D2 controls pulmonary metastasis of malignant melanoma cells. Nature (1979) 0.81
Pharmacology of synthetic thromboxane A2. Adv Prostaglandin Thromboxane Leukot Res (1987) 0.81
Thromboxane B2 (TxB2) release following acetyl glyceryl ether phosphorylcholine (AGEPC) infusion in the rabbit. Immunopharmacology (1983) 0.81
Leukotriene-induced contraction and thromboxane production in guinea-pig lung parenchymal strips. Eur J Pharmacol (1984) 0.81
Phase I study of 2-amino-5-bromo-6-phenyl-4(3H)-pyrimidinone (ABPP), an oral interferon inducer, in cancer patients. J Biol Response Mod (1986) 0.80
Modulation of pulmonary leukotriene formation and perfusion pressure by bestatin, an inhibitor of leukotriene A4 hydrolase. Biochem Pharmacol (1994) 0.79
Electron capture gas chromatographic detection of thromboxane B2. Prostaglandins (1977) 0.79
Glass capillary gas chromatography with electron-capture detection. Separation of prostaglandins. J Chromatogr (1979) 0.79
Arachidonic acid and 15(S)-hydroxy-5,8,11-cis-13-trans-eicosatetraenoic acid modulate human polymorphonuclear neutrophil activation by monocyte derived neutrophil activating factor. Biochem Biophys Res Commun (1987) 0.79
Inhibition of mitogen-activated protein kinase kinase blocks activation and redistribution of 5-lipoxygenase in HL-60 cells. Arch Biochem Biophys (1996) 0.79
A selective thromboxane synthetase inhibitor blocks the cAMP lowering activity of PGH2. Biochem Biophys Res Commun (1977) 0.78
Cardiovascular and renal actions of cytochrome P-450 metabolites of arachidonic acid. Blood Vessels (1989) 0.78
Oximes for high performance liquid and electron capture gas chromatography of prostaglandins and thromboxanes. Anal Chem (1977) 0.78
Transcellular biosynthesis of eicosanoids. Pharmacol Res (1989) 0.77